| 상품명칭 |
1,1'-(4,4,7,7-테트라메틸-4,7-디아자운데카메틸렌)비스-4-(3-메틸-2,3-디하이드로(벤조-1,3-티아졸)-2-메틸리덴)퀴놀리늄 |
| 별명 |
토토 1; 1,1'- (4,4,7,7- 테트라 메틸 -4,7- 디아 자운 데카 메틸렌) 비스 -4- (3- 메틸 -2,3- 디 하이드로 (벤조 -1,3- 티아 졸) -2- 메틸 리덴) 퀴놀리늄 테트라 요오드화물; 1,1'-(4,4,7,7-테트라메틸-4,7-디아자운데카메틸렌)-비스-4-(3-메틸-2,3-디하이드로-(벤조-1,3-티아졸)-2-메틸리덴)-퀴놀리늄 테트라요오드화물; 1,1'-(4,4,8,8-테트라메틸-4,8-디아자운데카메틸렌)비스(4-(3-메틸-2,3-디하이드로벤조-1,3-티아졸릴)-2-메틸리덴)퀴놀리늄 테트라요오드화물; 토토-1; 1,3- 프로판 디아 미니움, N, N, N ', N'- 테트라 메틸 -N, N'- 비스 (3- (4- ((3- 메틸 -2 (3H)-벤조티아졸리 리덴) 메틸) 퀴놀리늄 -1- 일) 프로필) -, 테트라 요오드화물; 퀴놀리늄, 1,1'-(1,3-프로판디일비스((디메틸이미니오)-3,1-프로판디일))비스(4-((3-메틸-2(3H)-벤조티아졸리덴)메틸)-, 테트라요오드화물; 1,1'-{프로판-1,3-디일비스[(디메틸암모니오)프로판-3,1-디일]}비스{4-[(Z)-(3-메틸-1,3-벤조티아졸-2(3H)-일리덴)메틸]퀴놀리늄} 테트라요오드화물 |
| 영문 이름 |
1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium;TOTO 1; 1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium tetraiodide; 1,1'-(4,4,7,7-Tetramethyl-4,7-diazaundecamethylene)-bis-4-(3-methyl-2,3-dihydro-(benzo-1,3-thiazole)-2-methylidene)-quinolinium tetraiodide; 1,1'-(4,4,8,8-Tetramethyl-4,8-diazaundecamethylene)bis(4-(3-methyl-2,3-dihydrobenzo-1,3-thiazolyl)-2-methylidene)quinolinium tetraiodide; Toto-1; 1,3-Propanediaminium, N,N,N',N'-tetramethyl-N,N'-bis(3-(4-((3-methyl-2(3H)-benzothiazolylidene)methyl)quinolinium-1-yl)propyl)-, tetraiodide; Quinolinium, 1,1'-(1,3-propanediylbis((dimethyliminio)-3,1-propanediyl))bis(4-((3-methyl-2(3H)-benzothiazolylidene)methyl)-, tetraiodide; 1,1'-{propane-1,3-diylbis[(dimethylammonio)propane-3,1-diyl]}bis{4-[(Z)-(3-methyl-1,3-benzothiazol-2(3H)-ylidene)methyl]quinolinium} tetraiodide |
| 분자식 |
C49H58I4N6S2 |
| 분자량 |
1302.7729 |
| InChI |
InChI=1/C49H58N6S2.4HI/c1-50-44-22-11-13-24-46(44)56-48(50)36-38-26-30-52(42-20-9-7-18-40(38)42)28-15-32-54(3,4)34-17-35-55(5,6)33-16-29-53-31-27-39(41-19-8-10-21-43(41)53)37-49-51(2)45-23-12-14-25-47(45)57-49;;;;/h7-14,18-27,30-31,36-37H,15-17,28-29,32-35H2,1-6H3;4*1H/q+4;;;;/p-4 |
| cas번호 |
143413-84-7 |
| 분자 구조 |
|
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
